Eric Verdin Explained

Eric Verdin
Birth Date: April 27, 1957
Birth Place:Liege, Belgium
Fields:Geroscientist
Workplaces:The Buck Institute for Research on Aging
Alma Mater:University of Leige
Harvard University

Eric M. Verdin is a Belgian geroscientist, researcher, and professor who has served as President and chief executive officer of the Buck Institute for Research on Aging since 2016.[1] [2] [3] Verdin’s research focuses on metabolism, diet, and the different proteins and molecules that affect the aging process and its associated diseases. He has published more than 210 papers and has more than 15 patents.

Life and career

Eric M. Verdin was born in Belgium.[4] He has a BS in Medical Sciences and doctorate of medicine from the University of Liege.

After graduating from university, Verdin trained at Harvard Medical School. In 1997, he joined the Gladstone Institute for Virology and Immunology, where he worked for twenty years. He ended his time there as associate director and senior investigator in the virology and immunology unit.

He is also a professor of medicine at the University of California, San Francisco.[5] He previously held faculty positions at the National Institutes of Health and at Picower Institute for Medical Research. He is on the scientific advisory board of Amazentis and previously served on the National Scientific Advisory Council of the American Federation for Aging Research.[6] He was a consultant to Calico, an aging-research company founded by Google.[7] He is an inventor on at least 15 published patents.

Verdin recreationally races race cars and trains for mental and physical endurance in LMP, Formula Atlantic and Formula 1 cars.[8]

The Buck Institute for Research on Aging

In November 2016, Verdin became president and CEO of the Buck Institute for Research on Aging.[9] The Buck Institute is the first independent research center focused solely on aging. As of 2022, it had an operating budget of $65 million a year and around 300 employees. The Buck’s first human clinical trial, Buck Institute Ketone Ester (BIKE), was announced in 2023.

Research focus areas

Verdin’s research has seen him focus on:

At Gladstone, Verdin researched the role of metabolism and diet in aging and on chronic diseases of aging, including Alzheimer’s. His research was particularly focused on the role of caloric restriction in increased health and lifespan.

His research focus at the Buck is on nutrition and how diet affects “the levels of key metabolites in the body, and how these in turn influence the immune response - especially the chronic inflammation associated with aging.” A few startups have been founded based on his work, including Napa Therapeutics, BHB Therapeutics, and Selah Therapeutics.[14]

Selected publications

Verdin has an h-index of 103[15] and has published more than 210 scientific papers including:[16]

External links

Notes and References

  1. Web site: CEO Eric Verdin Buck Institute . 2023-05-11 . www.bizjournals.com.
  2. Web site: 2022-07-28 . The Buck Institute, Where the Promise of Aging Research Isn’t Longevity . 2023-05-11 . proto.life . en-us.
  3. News: Buck Institute for Research on Aging names new CEO, announces $10M board donation. 2017-03-06. en.
  4. Web site: CEO Eric Verdin talks Buck Institute's new push to collaborate with pharma . 2023-05-11 . www.bizjournals.com.
  5. July 2020 . A SARS-CoV-2 protein interaction map reveals targets for drug repurposing . Nature . en . 583 . 7816 . 459–468 . 10.1038/s41586-020-2286-9 . 1476-4687. 7239059.
  6. Web site: 2023-05-25 . We’re on the verge of changing how we will age - Dr. Verdin . 2023-06-08 . Timeline Nutrition . en-US.
  7. Web site: 2017-01-02 . The Buck's new CEO tackles aging . 2023-06-15 . The North Bay Business Journal . en-US.
  8. Web site: Team Drivers . 2023-06-29 . The Karting Collective . en-US.
  9. Web site: Eric Verdin on the Buck, Nutrition, and Ketosis . 2023-05-23 . www.lifespan.io . en-US.
  10. Dahabieh . Matthew S. . Battivelli . Emilie . Verdin . Eric . 2015 . Understanding HIV latency: the road to an HIV cure . Annual Review of Medicine . 66 . 407–421 . 10.1146/annurev-med-092112-152941 . 1545-326X . 4381961 . 25587657.
  11. Web site: Science Behind Metabolic Switch Ketone Ester . 2023-07-14 . Juvenescence . en.
  12. Web site: Fan . Shelly . 2020-11-24 . Another Win for Senolytics: Fighting Aging at the Cellular Level Just Got Easier . 2023-06-15 . Singularity Hub . en-US.
  13. Web site: Buck Institute, Insilico Med and Juvenescence Found Napa Therapeutics to Focus on Age-Related Diseases . 2023-06-15 . BioSpace . en-US.
  14. News: Turner . Ben . 2019-10-03 . Exclusive Profile: The Buck Institute's Eric Verdin . en-GB . Longevity.Technology - Latest News, Opinions, Analysis and Research . 2023-06-22.
  15. Web site: Eric Verdin – Google Scholar Citations . scholar.google.com.
  16. Web site: 2016-11-25 . Novato's Buck gets $10M gift, names new CEO . 2023-05-16 . The North Bay Business Journal . en-US.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Eric Verdin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.